Posts Tagged ‘MOSAIQ’
Do your plans include demonstrating meaningful use and qualifying for HITECH Act incentive money? If so, don’t miss Elekta’s complimentary January webinars.
HITECH 101 (Monday, January 23, 2 p.m. Eastern / 11 a.m. Pacific)
Will include updated information about proving meaningful use that will have a direct impact on every practice that intends to pursue incentive funds. This session is geared for customers in the early stages of planning for meaningful use and the HITECH Act. This session will be facilitated by Sima Aziz, Business Line Manager, Medical Oncology and HITECH. Click Here to Register
HITECH 201 (Thursday, January 26, 2 p.m. Eastern / 11 a.m. Pacific)
Providers can demonstrate meaningful use by attestation if they begin in either 2011 or 2012 – and more than 14,000 have registered to do so. Our goal is to give you the information you need to qualify for the first-year incentive money whether you begin in this year or next. The session will be facilitated by Natalie Hoad-Reddick, Product Manager for General Charting and Medical Oncology. Click Here to Register
NEW! HITECH 301 (Friday, January 27, 2 p.m. Eastern / 11 a.m. Pacific)
Details coming soon! The session will be facilitated by Faye Ann MacDonald, Senior Product Manager for General Charting and Medical Oncology. Click Here to Register
MOSAIQ® customers are encouraged to visit SupportPlus to learn more about the HITECH Act, meaningful use certification and how MOSAIQ has been modified to address meaningful use criteria. Information may also be found at www.elekta.com/hitech.
Elekta's MOSAIQ Oncology Information System
In the coming months, join us in Columbus, Ohio and Portland, Oregon for an interactive and engaging afternoon with Elekta’s MOSAIQ® Oncology Information System. We’ll share what’s new, what’s coming, and provide information to perfect your practice, refine your workflow and supply the support you need in this dynamic business. To view the agenda, please click here: MOSAIQ Symposia.
February 16, 2012 • Columbus, Ohio
Renaissance Columbus Downtown
April 5, 2012 • Portland, Oregon
The Westin Portland
Target audience: Intermediate to advanced MOSAIQ users; members of your administrative leadership, healthcare industry consultants and thought leaders, members of the care and treatment teams.
*Registration is complimentary, but may be limited. To register, click here. ASRT and MDCB credits will be applied for.
Among oncology software products, customers ranked Elekta first for its MOSAIQ® Oncology Information System (OIS) in a survey by KLAS, an independent research firm. The recently released 2011 Best in KLAS Awards: Software & Services* report showed that MOSAIQ scored 79.1 out of 100 and 88 percent of customers indicated they would buy again. The report, which puts MOSAIQ at the top for 2011, is a summary of performance data collected over the past 12 months and ranks the top overall vendors, as well as leaders in each market segment.
The award will be presented to Elekta at the Healthcare Information and Management Systems Society (HIMSS) Conference & Exhibition in February 2012 in Las Vegas. Elekta experts, available at booth #1455 will be providing MOSAIQ demonstrations during the exhibition, highlighting the OIS’s unparalleled open systems and interface connectivity to the widest range of treatment planning, treatment delivery, LIS, brachytherapy systems and hospital information systems.
“We are enormously gratified that our customer respondents in the KLAS survey recognized the value of MOSAIQ for managing their patients’ care,” says Todd Powell, Executive Vice President, Elekta Software. “A continually evolving solution since 1992, MOSAIQ OIS was developed not only to streamline complex oncology workflows, but also to enable clinics to integrate vendor-neutral hardware and software as their needs change.”
More than 1,400 U.S. cancer treatment centers trust MOSAIQ to manage their patient information and provide unmatched connectivity to enterprise systems.
*2011 Best in KLAS Awards: Software & Services,” December, 2011. © 2011 KLAS Enterprises, LLC. All rights reserved. www.KLASresearch.com
Read more at: http://www.elekta.com/healthcare_international_press_release_20071327.php.
U.K. medical center acquires two Elekta Synergy treatment systems, MOSAIQ oncology information system and IGRT workspace
The radiation oncology department at internationally renowned Addenbrooke’s Hospital (Cambridge, U.K.) is upgrading its radiotherapy capabilities with Elekta therapy systems, oncology information system (OIS) and image guided workspace. The two Elekta Synergy® image guided radiation therapy (IGRT) systems replace one Siemens linear accelerator and one Varian linear accelerator that had been in service for more than 10 years at the medical center, which is run by the Cambridge University Hospitals NHS Foundation Trust.
Officials at Addenbrooke’s have been eager to more fully exploit techniques and technologies that modern treatment machines provide, according to Simon Thomas, Ph.D., head of radiotherapy physics at Addenbrooke’s. Currently, the hospital treats between 200 and 250 patients each day on seven machines.
“The two capabilities we wanted on the machines were IGRT and VMAT,” he says. “IGRT provides images of the target and nearby critical structures we want to avoid – with the patient in the treatment position before therapy. With VMAT, single or multiple radiation beams sweep in uninterrupted arcs around the patient, significantly reducing treatment times.”
Acquiring additional IGRT- and VMAT-capable treatment machines will enable Addenbrooke’s clinicians to offer these imaging and therapy techniques to more patients, Dr. Thomas adds.
Addenbrooke’s Hospital asked Elekta and three other providers to submit proposals and give presentations on their equipment to replace the outgoing linear accelerators. “We compared each company against our clinical and financial requirements and developed an overall score,” Dr. Thomas says. “Elekta’s overall score came out highest, and we combined that with the positive opinions we gathered from other Elekta users in the U.K., and decided to go with Elekta’s offerings.”
Read more at: http://www.elekta.com/healthcare_international_press_release_20071324.php.
Do your plans include demonstrating meaningful use and qualifying for HITECH Act incentive money? If so, don’t miss Elekta’s complimentary December webinars. This month’s sessions will be broken into two sections, and focus on MOSAIQ® version 2.3.
HITECH 101 (Tuesday, December 20, 11 a.m. ET) will include updated information about proving meaningful use that will have a direct impact on every practice that intends to pursue incentive funds. This session will be geared for customers who are at the early stages of planning for Meaningful Use and the HITECH Act. This session will be facilitated by Sima Aziz, Business Line Manager, Medical Oncology and HITECH. Click Here to Register.
HITECH 201 (Wednesday, December 21, 2 p.m. ET) Providers can demonstrate meaningful use by attestation if they begin in either 2011 or 2012 – and more than 14,000 have already registered to do so. Our goal is to give you the information you need to qualify for the first-year incentive money whether you begin in this year or next. The session will be facilitated by Natalie Hoad-Reddick, Product Manager for General Charting and Medical Oncology. Click Here to Register.
Current MOSAIQ customers are encouraged to visit SupportPlus to learn more about the HITECH Act, meaningful use certification and how MOSAIQ has been modified to address the meaningful use criteria. In addition, updated information may also be found at www.elekta.com/hitech.
Do your plans include demonstrating meaningful use and qualifying for HITECH Act incentive money? If so, don’t miss Elekta’s complimentary October webinars. This month’s sessions will be broken into two sections, and focus on MOSAIQ® version 2.3.
HITECH 101 (Monday, October 24, 2 p.m. ET) will include updated information about proving meaningful use that will have a direct impact on every practice that intends to pursue incentive funds. This session will be geared for customers who are at the early stages of planning for Meaningful Use and the HITECH Act. This session will be facilitated by Sima Aziz, Business Line Manager, Medical Oncology and HITECH. Click Here to Register.
HITECH 201 (Friday, October 28, 1 p.m. ET) Providers can demonstrate meaningful use by attestation if they begin in either 2011 or 2012 – and more than 14,000 have already registered to do so. Our goal is to give you the information you need to qualify for the first-year incentive money whether you begin in this year or next. The session will be facilitated by Natalie Hoad-Reddick, Product Manager for General Charting and Medical Oncology. Click Here to Register.
Current MOSAIQ customers are encouraged to visit SupportPlus to learn more about the HITECH Act, meaningful use certification and how MOSAIQ has been modified to address the meaningful use criteria. In addition, updated information may also be found at www.elekta.com/hitech.
Do your plans include demonstrating meaningful use and qualifying for HITECH Act incentive money? If so, don’t miss Elekta’s complimentary September webinars. This month’s sessions will be broken into two sections, and focus on MOSAIQ® version 2.3.
HITECH 101 (Friday, September 16, 4 p.m. ET) will include updated information about proving meaningful use that will have a direct impact on every practice that intends to pursue incentive funds. This session will be geared for customers who are at the early stages of planning for Meaningful Use and the HITECH Act. This session will be facilitated by Sima Aziz, Business Line Manager, Medical Oncology and HITECH. Click Here to Register.
HITECH 201 (Tuesday, September 27, 1 p.m. ET) Providers can demonstrate meaningful use by attestation if they begin in either 2011 or 2012 – and more than 14,000 have already registered to do so. Our goal is to give you the information you need to qualify for the first-year incentive money whether you begin in this year or next. The session will be facilitated by Faye Ann MacDonald, Senior Product Manager for Medical Oncology and General Charting. Click Here to Register.
Current MOSAIQ customers are encouraged to visit SupportPlus to learn more about the HITECH Act, meaningful use certification and how MOSAIQ has been modified to address the meaningful use criteria. In addition, updated information may also be found at www.elekta.com/hitech.
- Largest Neurosurgical Center in Russia Acquires Elekta’s Leksell Gamma Knife Perfexion February 6, 2012Russia’s first Leksell Gamma Knife® Perfexion™ system has found a home at the renowned N.N. Burdenko Neurosurgical Institute, just a five-minute car ride from Moscow’s Red Square. On June 2, 2011, a 59-year-old woman was the first Perfexion patient, receiving Gamma Knife® radiosurgery to treat tumor tissue that remained following open surgery. Now, eight mon […]
- Largest Neurosurgical Center in Russia Acquires Elekta’s Leksell Gamma Knife Perfexion February 6, 2012N.N. Burdenko Neurosurgical Institute improves treatment of patients with multiple metastasesRead more... […]
- SRT January 31, 2012Würzburg10-11 December - 2012 […]
- Mosaiq® - Electronic Medical Records January 31, 2012Mannheim26-27 November - 2012 […]
- IMRT / VMAT January 31, 2012Mannheim22-23 November - 2012 […]
- IGRT January 31, 2012Amsterdam16-17 November - 2012 […]
- SBRT January 31, 2012Wake Forest, North Carolina18-19 October - 2012 […]
- IGRT January 31, 2012Amsterdam29-30 June - 2012 […]
- IMRT / VMAT January 31, 2012Mannheim21-22 June - 2012 […]
- Mosaiq® - Electronic Medical Records January 31, 2012Mannheim18-19 June - 2012 […]